Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7133
Rank
NZ$0.91 B
Marketcap
NZ$45.72
Share price
0.83%
Change (1 day)
-25.74%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement